We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$655M
AUM Growth
+$3.66M
Cap. Flow
+$9.57M
Cap. Flow %
1.46%
Top 10 Hldgs %
32.39%
Holding
187
New
13
Increased
39
Reduced
92
Closed
8

Top Buys

Rank Stock Value
1
SOLV icon
Solventum
SOLV
+$4.39M
2
CRM icon
Salesforce
CRM
+$3.93M
3
WTRG icon
Essential Utilities
WTRG
+$3.55M
4
TDC icon
Teradata
TDC
+$3.44M
5
HAL icon
Halliburton
HAL
+$3.15M

Sector Composition

Rank Sector Weight
1 Technology 33.86%
2 Healthcare 16.16%
3 Industrials 15.33%
4 Utilities 10.02%
5 Energy 6.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VNT icon
76
Vontier
VNT
$4.78B
$2.47M 0.38%
64,647
-450
-0.7% -$18.1K
ALB icon
77
Albemarle
ALB
$14.3B
$2.44M 0.37%
25,525
+10,600
+71% +$1.26M
ASTE icon
78
Astec Industries
ASTE
$1.21B
$2.42M 0.37%
81,743
+41,641
+104% +$1.5M
A icon
79
Agilent Technologies
A
$39.3B
$2.41M 0.37%
18,576
-200
-1% -$28K
UTHR icon
80
United Therapeutics
UTHR
$21.9B
$2.37M 0.36%
7,450
-300
-4% -$79.4K
SNOW icon
81
Snowflake
SNOW
$110B
$2.36M 0.36%
17,450
+7,018
+67% +$1.04M
BE icon
82
Bloom Energy
BE
$67.9B
$2.26M 0.34%
184,400
+156,700
+566% +$2M
ARCB icon
83
ArcBest
ARCB
$3.22B
$2.25M 0.34%
21,025
-200
-0.9% -$24.1K
XRAY icon
84
Dentsply Sirona
XRAY
$2.86B
$2.09M 0.32%
83,923
-86,922
-51% -$2.49M
CCK icon
85
Crown Holdings
CCK
$13.2B
$2.08M 0.32%
27,939
-350
-1% -$28.2K
SO icon
86
Southern Company
SO
$107B
$2.02M 0.31%
26,093
+293
+1% +$22.2K
NEE icon
87
NextEra Energy
NEE
$182B
$1.89M 0.29%
26,647
BCE icon
88
BCE
BCE
$20.5B
$1.84M 0.28%
56,832
-159,697
-74% -$5.32M
ILMN icon
89
Illumina
ILMN
$30.5B
$1.77M 0.27%
+16,950
New +$1.9M
BCV
90
Bancroft Fund
BCV
$138M
$1.51M 0.23%
96,522
-4,600
-5% -$71K
BAX icon
91
Baxter International
BAX
$14.6B
$1.38M 0.21%
41,179
-21,928
-35% -$808K
WBS icon
92
Webster Financial
WBS
$12.6B
$1.34M 0.2%
30,750
-750
-2% -$33.4K
MRNA icon
93
Moderna
MRNA
$22.9B
$1.34M 0.2%
11,250
-150
-1% -$19K
VWO icon
94
Vanguard FTSE Emerging Markets ETF
VWO
$123B
$1.21M 0.18%
27,669
-600
-2% -$25.8K
ACVA icon
95
ACV Auctions
ACVA
$1.38B
$1.21M 0.18%
66,284
DAN icon
96
Dana Inc
DAN
$2.99B
$1.18M 0.18%
97,412
+1,100
+1% +$14.3K
KMI icon
97
Kinder Morgan
KMI
$70B
$1.17M 0.18%
58,720
-400
-0.7% -$7.63K
EQNR icon
98
Equinor
EQNR
$93.1B
$1.11M 0.17%
38,800
+21,100
+119% +$588K
PBW icon
99
Invesco WilderHill Clean Energy ETF
PBW
$428M
$1.08M 0.17%
53,700
-34,000
-39% -$731K
CVX icon
100
Chevron
CVX
$378B
$1.04M 0.16%
6,662
+61
+0.9% +$9.73K

Similar funds

John G. Ullman & Associates's Q2 2024 Portfolio in Review

As of Q2 2024, John G. Ullman & Associates held 187 positions worth $655M, up 0.56% from $652M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

John G. Ullman & Associates's Q2 2024 filing shows 13 new, 39 increased, 92 reduced and 8 closed positions. Its largest new stake was Solventum: 72,250 shares worth $3.82M. The largest sale was Argan, an estimated $6.04M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Industrials.

  • John G. Ullman & Associates's largest Q2 2024 buy was Solventum: 72,250 shares worth $3.82M.
  • John G. Ullman & Associates added most to Halliburton in Q2 2024, an estimated $3.15M increase.
  • John G. Ullman & Associates's biggest Q2 2024 reduction was Argan, cutting an estimated $6.04M.
  • John G. Ullman & Associates fully exited Hewlett Packard in Q2 2024, selling an estimated $505K.
  • John G. Ullman & Associates's ten largest holdings make up 32% of its $655M portfolio in Q2 2024.
  • John G. Ullman & Associates opened 13 new positions and closed 8 in Q2 2024.
  • John G. Ullman & Associates's portfolio value rose 0.56% quarter-over-quarter to $655M.

Based on John G. Ullman & Associates's 13F filing for Q2 2024, filed 8 Aug 2024.